Tom Hughes, PhD
CEO, Navitor Pharmaceuticals
Tom Hughes has more than 30 years of industry experience in the discovery, development and commercialization of pharmaceutical products. Tom has served since 2018 as CEO of Navitor Pharmaceuticals, a privately held biopharmaceutical company.
Prior to joining Navitor, Tom served as President and Chief Scientific Officer, and earlier as CEO of Zafgen Inc. Prior to Zafgen, Tom held several positions at Novartis including Global Head of the Cardiovascular and Metabolic Diseases Therapeutic Area at the Novartis Institutes for BioMedical Research. He oversaw many drug discovery and development projects targeting major global aging-related health issues including obesity, diabetes, and heart disease.